Dissection of Kinase Isoforms through Orthogonal and Chemical Inducible Signaling Cascades
暂无分享,去创建一个
Xinyuan Fan | Jingyi Zhao | Siqi Zheng | Jingyi Zhao | Jie Wang | Peng R Chen | Siqi Zheng | Jie Wang | Xinyuan Fan | Peng Chen
[1] Jared E. Toettcher,et al. Using Optogenetics to Interrogate the Dynamic Control of Signal Transmission by the Ras/Erk Module , 2013, Cell.
[2] Boris N. Kholodenko,et al. Feedback regulation in cell signalling: Lessons for cancer therapeutics. , 2016, Seminars in cell & developmental biology.
[3] J. Charron,et al. Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta , 1999, Current Biology.
[4] N. Ahn,et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. , 1994, Science.
[5] T. Voss,et al. MEK1 and MEK2, Different Regulators of the G1/S Transition* , 2004, Journal of Biological Chemistry.
[6] M. Tremblay,et al. Mek2 Is Dispensable for Mouse Growth and Development , 2003, Molecular and Cellular Biology.
[7] B. Turk. Discovery and development of anthrax lethal factor metalloproteinase inhibitors. , 2008, Current Pharmaceutical Biotechnology.
[8] D. Bowtell,et al. A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment. , 2012, Cancer research.
[9] Peng R. Chen,et al. Diels-Alder reaction-triggered bioorthogonal protein decaging in living cells. , 2014, Nature chemical biology.
[10] Wendell A. Lim,et al. Bacterial Virulence Proteins as Tools to Rewire Kinase Pathways in Yeast and Immune Cells , 2012, Nature.
[11] D. Mercola,et al. Egr1 Transcription Factor: Multiple Roles in Prostate Tumor Cell Growth and Survival , 2002, Tumor Biology.
[12] R. Roskoski. MEK1/2 dual-specificity protein kinases: structure and regulation. , 2012, Biochemical and biophysical research communications.
[13] J. Arthur,et al. Mitogen-activated protein kinases in innate immunity , 2013, Nature Reviews Immunology.
[14] S. Leppla,et al. Cellular and systemic effects of anthrax lethal toxin and edema toxin. , 2009, Molecular aspects of medicine.
[15] B. Kholodenko. Cell-signalling dynamics in time and space , 2006, Nature Reviews Molecular Cell Biology.
[16] Jason W. Chin,et al. Selective, rapid and optically switchable regulation of protein function in live mammalian cells. , 2015, Nature chemistry.
[17] C. Berking,et al. MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study. , 2013, The Lancet. Oncology.
[18] Mark Merchant,et al. Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition. , 2012, Cancer research.
[19] J. Pouysségur,et al. ERK implication in cell cycle regulation. , 2007, Biochimica et biophysica acta.
[20] Jie Li,et al. Bioorthogonal Chemical Activation of Kinases in Living Systems , 2016, ACS central science.
[21] J. Ballard,et al. Clostridium difficile Toxins: Mechanism of Action and Role in Disease , 2005, Clinical Microbiology Reviews.
[22] Michael Z. Lin,et al. Optical control of cell signaling by single-chain photoswitchable kinases , 2017, Science.
[23] D. Teis,et al. Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. , 2002, Developmental cell.
[24] Huitu Liu,et al. MAPK signal pathways in the regulation of cell proliferation in mammalian cells , 2002, Cell Research.
[25] Pradeep Kota,et al. Engineered allosteric activation of kinases in living cells , 2010, Nature Biotechnology.
[26] M. Baccarini,et al. MEK1 Is Required for PTEN Membrane Recruitment, AKT Regulation, and the Maintenance of Peripheral Tolerance , 2013, Molecular cell.
[27] A. Brunet,et al. Growth factor‐stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1) , 1994, FEBS letters.
[28] Peter G. Schultz,et al. A chemical switch for inhibitor-sensitive alleles of any protein kinase , 2000, Nature.
[29] C. Montecucco,et al. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity. , 2009, Molecular aspects of medicine.
[30] Xudong Liang,et al. Anthrax Lethal Factor Proteolysis and Inactivation of MAPK Kinase* , 2003, The Journal of Biological Chemistry.